BKDBrookdale Senior Living Inc.
Is the price fair?
A demanding price: priced for +33% a year vs +1% a year delivered and rich vs its sector.
Priced for ~33% a year FCF growth. The price already bakes in strong, sustained growth.
Sector median 22.6× across 130 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
All from derived, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What BKD's price assumes
Brookdale Senior Living Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 1.21× revenue.
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 0.64%
Free cash flow yield · Medical Care Facilities median 7.1%
- Growth the price implies
- +33%
Growth the price implies · The price pays for +33% free cash flow growth a year for a decade; revenue has grown +0.99% a year over the last three.
- EV / sales
- 2.48
EV / sales
Details›
- EV / EBITtoday's price, trailing year to Jun 30, 2026
- 71.3
- EV / salestoday's price, trailing year to Jun 30, 2026
- 2.48
- Free cash flow, trailing twelve months
- $24M
- Market capitalisation
- $3.68B
- 3-year revenue growth
- +0.99%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Care Facilities
Ranks #25 of 27 by RyuScore